| Bioactivity | Y02224 is a potent BRD4 inhibitor and exhibits reasonable antiproliferative effect on leukemia cells.Y02224 has the potential for? CRPC research[1]. |
| Target | IC50: BRD4 |
| Name | Y02224 |
| CAS | 1853988-48-3 |
| Formula | C20H17BrN2O4S |
| Molar Mass | 461.33 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Maofeng Zhang, et al. Structure-Based Discovery and Optimization of Benzo[ d]isoxazole Derivatives as Potent and Selective BET Inhibitors for Potential Treatment of Castration-Resistant Prostate Cancer (CRPC). J Med Chem. 2018 Apr 12;61(7):3037-3058. |
Y02224
CAS: 1853988-48-3 F: C20H17BrN2O4S W: 461.33
Y02224 is a potent BRD4 inhibitor and exhibits reasonable antiproliferative effect on leukemia cells.Y02224 has the pote
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.